Quality of life in low-grade glioma patients receiving temozolomide.

Neuro-oncology
Raymond LiuSusan M Chang

Abstract

The purpose of this study was to describe the quality of life (QOL) of low-grade glioma (LGG) patients at baseline prior to chemotherapy and through 12 cycles of temozolomide (TMZ) chemotherapy. Patients with histologically confirmed LGG with only prior surgery were given TMZ for 12 cycles. QOL assessments by the Functional Assessment of Cancer Therapy-Brain (FACT-Br) were obtained at baseline prior to chemotherapy and at 2-month intervals while receiving TMZ. Patients with LGG at baseline prior to chemotherapy had higher reported social well-being scores (mean difference = 5.0; p < 0.01) but had lower reported emotional well-being scores (mean difference = 2.2; p < 0.01) compared to a normal population. Compared to patients with left hemisphere tumors, patients with right hemisphere tumors reported higher physical well-being scores (p = 0.01): 44% could not drive, 26% did not feel independent, and 26% were afraid of having a seizure. Difficulty with work was noted in 24%. Mean change scores at each chemotherapy cycle compared to baseline for all QOL subscales showed either no significant change or were significantly positive (p < 0.01). Patients with LGG on TMZ at baseline prior to chemotherapy reported QOL comparable to a nor...Continue Reading

References

May 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·M J TaphoornA B Karim
Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R MacdonaldJ G Cairncross
Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F CellaJ Brannon
Mar 1, 1997·Brain and Language·J L Cummings
Feb 19, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G M KiebertA B Karim
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S SmithR B Jenkins
Sep 8, 2000·The Journal of the American Academy of Psychoanalysis·J Wasserstein, G A Stefanatos
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francesco PignattiUNKNOWN European Organization for Research and Treatment of Cancer Radiotherapy Cooperative Group
Aug 27, 2002·Journal of Neurology·Jan J Heimans, Martin J B Taphoorn
Feb 28, 2003·International Journal of Radiation Oncology, Biology, Physics·C A HahnE C Halperin
Jun 28, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul D BrownEdward G Shaw
Aug 23, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·A MainioP Räsänen
Nov 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M BradaC Westbury
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Hoang-XuanJ Y Delattre
Feb 26, 2005·The British Journal of Radiology·S-A YehE-Y Huang
Jun 21, 2005·International Journal of Radiation Oncology, Biology, Physics·Nadia N LaackUNKNOWN North Central Cancer Treatment Group
Sep 20, 2005·Lancet·M J van den BentUNKNOWN EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council
Mar 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frederick F Lang, Mark R Gilbert
May 20, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Margareta GustafssonGerd Ahlström
Jun 24, 2006·The Oncologist·Jeanine T Grier, Tracy Batchelor
Jun 5, 2007·Cancer·Jolie RingashDonald A Redelmeier
Jul 12, 2007·Clinical Journal of Oncology Nursing·Leesa VitekSusan Stollings

❮ Previous
Next ❯

Citations

Apr 29, 2010·Current Neurology and Neuroscience Reports·Nader Pouratian, David Schiff
Nov 1, 2012·Neuro-oncology·Rakesh Jalali, Debnarayan Dutta
May 29, 2010·The Oncologist·Martin J B TaphoornAndrew Bottomley
Feb 15, 2011·Journal of Neurosurgery·Asgeir S JakolaOle Solheim
Mar 26, 2016·Journal of Neurosurgery·Christina DrewesOle Solheim
Jan 2, 2015·Neurosurgical Focus·Elizabeth B ClausMargaret Wrensch
Feb 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Florien W BoeleMartin Klein
Jul 13, 2011·Journal of Neuro-oncology·Harsha Prasada LashkariStergios Zacharoulis
Jun 14, 2014·Current Oncology Reports·Amulya A Nageswara Rao, Roger J Packer
Mar 26, 2014·The Oncologist·Deborah A ForstTracy T Batchelor
Jul 16, 2019·PLoS Computational Biology·Víctor M Pérez-GarcíaJuan Sepúlveda
Nov 20, 2016·Acta Neurologica Scandinavica·M J TantiM D Jenkinson
Aug 7, 2019·Neuro-oncology Practice·Amélie DarlixMarie Blonski
Dec 9, 2020·Neurosurgery·Ramin A MorshedShawn L Hervey-Jumper
Feb 16, 2021·Neurosurgery·Christina Weyer-JamoraJennie W Taylor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Cagdas YavasFadil Akyol
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
David OsobaMichael D Prados
Annals of Oncology : Official Journal of the European Society for Medical Oncology
Michael BradaC Westbury
© 2022 Meta ULC. All rights reserved